Santen Pharmaceutical Co Financial Overview
Santen Pharmaceutical Co's market cap is currently $3.40B. The company's EPS TTM is $0.166; its P/E ratio is 16.99; and it has a dividend yield of 2.02%. Santen Pharmaceutical Co is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
